Ariane has significant expertise in science, research, health and innovation, with experience across both industry and the public sector. After completing a PhD in Biomedical Science from Victoria University of Wellington (anti-cancer drug discovery), Ariane held a number of roles at Volpara Health Technologies Ltd, which included leading global medical affairs and clinical research, and product management of AI-powered medical device software. Following a role as the Strategic Partnerships Manager at the Institute of Environmental Science and Research (ESR), she now works as the Lead, Non-communicable Diseases for the Polynesian Health Corridors Programme, based at Manatū Hauora.

Ariane is very familiar with many of the challenges faced by the rare disorders community and is privileged to serve on the RDNZ Board, being appointed in 2024. She was diagnosed with an autoimmune condition 6+ years after first presenting to her GP, and also has someone in her whānau living with the rare disorder, Biliary Atresia.

Ariane Chan

Our Collective

Rare Disorders NZ is the collective voice of all people living with a rare disorder and their whānau. Our rare collective is made up of more than 150 disorder-specific support groups.

Our work is informed by the issues important to our collective. We work together to improve healthcare and wellbeing for everyone living with a rare health condition in New Zealand.

Learn more